Preliminary study of the safety and efficacy of SC-58 635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. - Simon,L.S.; Lanza,F.L.; Lipsky,P.E.; Hubbard,R.C.; Talwalker,S.; Schwartz,B.D.; Isakson,P.C.; Geis,S.G. (Arthritis Rheum, 1998)